Literature DB >> 29350243

Current opinions on nephrolithiasis associated with primary hyperparathyroidism.

Xiaoming Cong1, Luming Shen1, Xiaojian Gu2.   

Abstract

Nephrolithiasis is a common urological disease and could be secondary to primary hyperparathyroidism (PHPT). PHPT is traditionally characterised with hypercalcaemia. Recently, a normocalcemic PHPT has been officially recognised at the International Workshops. Regarding this new phenotype, nephrolithiasis is frequently found in studies that evaluate low bone mass. However, until now, no study on aetiology of nephrolithiasis considered normocalcemic PHPT. Hypercalciuria related to PHPT is considered as an important risk factor of stone formation in hypercalcemic PHPT, but the precise relationships between hypercalcemic PHPT and nephrolithiasis and between normocalcemic PHPT and nephrolithiasis remain unclear. In patients with hypercalcemic PHPT, after a surgical cure of PHPT, the renal calcium excretion and stone recurrence rate reduce but remain higher above health controls. This finding implies that abnormalities not caused by PHPT also probably affect stone formation. According to the new guideline, the presence of stones indicates the need for parathyroidectomy in patients with either hypercalcemic or normocalcemic PHPT unless contraindications exist. Patients with contraindications for parathyroidectomy or those who do not want to receive parathyroidectomy should be monitored for signs of disease progression and given of medical management. Moreover, due to decreased but significantly higher frequency of nephrolithiasis above those of healthy controls, patients with nephrolithiasis associated with PHPT after parathyroidectomy still should be motivated to explore strategies to prevent stone occurrence.

Entities:  

Keywords:  Diagnosis; Hypercalcaemia; Management; Nephrolithiasis; Normocalcemia; Pathophysiology; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2018        PMID: 29350243     DOI: 10.1007/s00240-018-1038-x

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  60 in total

Review 1.  Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis.

Authors:  Giuseppe Vezzoli; Annalisa Terranegra; Laura Soldati
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

2.  Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?

Authors:  Gang Chen; Ying Xue; Qiongyao Zhang; Ting Xue; Jin Yao; Huibin Huang; Jixing Liang; Liantao Li; Wei Lin; Lixiang Lin; Lidan Shi; Liangchun Cai; Junping Wen
Journal:  J Clin Endocrinol Metab       Date:  2015-02-10       Impact factor: 5.958

3.  Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region.

Authors:  Giuseppe Vezzoli; Annalisa Terranegra; Teresa Arcidiacono; Giovanni Gambaro; Luciano Milanesi; Ettore Mosca; Laura Soldati
Journal:  Nephrol Dial Transplant       Date:  2010-01-12       Impact factor: 5.992

4.  Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism.

Authors:  G A Lumb; S W Stanbury
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

Review 5.  Nephrolithiasis and renal calcifications in primary hyperparathyroidism.

Authors:  Lars Rejnmark; Peter Vestergaard; Leif Mosekilde
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

6.  Normocalcemic primary hyperparathyroidism in patients with recurrent kidney stones: pathological analysis of parathyroid glands.

Authors:  An-Hang Yang; Chih-Wei Hsu; Jui-Yu Chen; Ling-Ming Tseng; Ging-Shing Won; Chen-Hsen Lee
Journal:  Virchows Arch       Date:  2006-05-03       Impact factor: 4.064

7.  Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

Authors:  Andrew Grey; Jenny Lucas; Anne Horne; Greg Gamble; James S Davidson; Ian R Reid
Journal:  J Clin Endocrinol Metab       Date:  2005-01-11       Impact factor: 5.958

8.  Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy.

Authors:  C L Mollerup; H Lindewald
Journal:  World J Surg       Date:  1999-02       Impact factor: 3.352

Review 9.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

10.  Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones.

Authors:  Andrew E Evan; James E Lingeman; Fredric L Coe; Nicole L Miller; Sharon B Bledsoe; Andre J Sommer; James C Williams; Youzhi Shao; Elaine M Worcester
Journal:  Kidney Int       Date:  2008-04-30       Impact factor: 10.612

View more
  4 in total

1.  Inhibitory role of microRNA-484 in kidney stone formation by repressing calcium oxalate crystallization via a VDR/FoxO1 regulator axis.

Authors:  Li Fan; Hai Li; Wei Huo
Journal:  Urolithiasis       Date:  2022-10-13       Impact factor: 2.861

2.  Discovery of primary hyperparathyroidism following an endoscopic resection of the prostate: case report.

Authors:  Jordan Thomas; Adrian Khelif; Shrine Arulanantham; Jean Lemaitre; Jean-Emmanuel Lalive d'Epinay
Journal:  J Surg Case Rep       Date:  2022-05-27

3.  Occurrence of Klinefelter Syndrome Mosaic 45,X/46,XY/47,XXY/48,XXYY/48,XXXY and Primary Hyperparathyroidism.

Authors:  César Ernesto Lam-Chung; Larissa López Rodríguez; Yayoi Segura Kato; Iván Josué Jiménez González; Lourdes Mena-Hernández; Renata Rivera-Juárez; Paloma Almeda-Valdes; Jazmín Arteaga Vázquez
Journal:  AACE Clin Case Rep       Date:  2021-03-13

Review 4.  Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism.

Authors:  Giovanni Lombardi; Ewa Ziemann; Giuseppe Banfi; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.